• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Synexus aquires Osteomed of Poland

Synexus aquires Osteomed of Poland

May 2, 2012
CenterWatch Staff

Synexus, a global company that recruits and runs late phase clinical trials, has further strengthened its leadership position in Poland with the acquisition of Warsaw-based Osteomed for an undisclosed sum.

Synexus will combine its own Warsaw facility with Osteome and house it in a new research clinic four times the size of Synexus’ current Warsaw facility.

Christophe Berthoux, CEO of Synexus, said, “Synexus has long recognized the importance of Poland in the global clinical trials market in terms of the significant opportunities this region can offer. We have had a well-established presence in Poland for a number of years but felt that now was the time to further strengthen this, both in recognition of the area as well as in support of our business growth. The acquisition of Osteomed will enhance our capacity, brings us scientific expertise and experience in the field of bone diseases and access to an extensive patient database.”

Analysts have predicted that the global clinical trials market in Poland will grow to reach $323 million by 2015, offering attractive benefits including access to high quality medical expertise, significant cost advantages, a motivated patient population and excellent trial data quality.

”It also creates a third pillar in our global infrastructure,” continued Berthoux. “We have 24 sites across the world and a significant presence in the U.K., Germany and now Poland. Synexus’ success in Poland will be used as a platform to grow our business across Central and Eastern Europe where we already have clinics in Hungary, Ukraine and Bulgaria. This infrastructure enables us to offer scale and capacity to clients as well as stability which are seen as vital by the pharmaceutical industry.”

Owners of Osteomed, Andrzej Sawicki and Piotr Sawicki, will remain with Synexus in senior positions.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing